Medical Ikkou Group Co., Ltd. (JP:3353)
:3353
3353 Stock Chart & Stats
¥2930.00
¥4.00(0.19%)
At close: 4:00 PM EST
¥2930.00
¥4.00(0.19%)
Day’s Range― - ―
52-Week Range¥2,150.00 - ¥4,410.00
Previous CloseN/A
Volume1.00K
Average Volume (3M)5.09K
Market Cap
¥10.13B
Enterprise Value¥15.21B
Total Cash (Recent Filing)¥8.60B
Total Debt (Recent Filing)¥11.43B
Price to Earnings (P/E)9.0
Beta0.44
Next Earnings
Jul 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.51%
Share Statistics
EPS (TTM)87.16
Shares Outstanding3,770,000
10 Day Avg. Volume10,430
30 Day Avg. Volume5,086
Financial Highlights & Ratios
PEG Ratio0.73
Price to Book (P/B)0.73
Price to Sales (P/S)0.21
P/FCF Ratio52.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Revenue GrowthSustained top-line acceleration across recent annual periods signals improving market traction and demand for the company’s offerings. Durable revenue momentum supports capacity utilization, strategic reinvestment and greater scale economics over the next several months, reducing execution risk.
Deleveraging And Balance-Sheet StrengthMeaningful reduction in leverage improves financial flexibility and lowers default risk, enabling continued investment or targeted M&A without excessive refinancing pressure. A stronger balance sheet supports long-term strategic choices and resilience through industry cycles.
Consistent Positive Free Cash FlowAcross the reported period the company generates positive free cash flow annually, providing a base to fund dividends, capex and debt paydown. Even if amounts vary, persistent FCF availability is a durable source to support shareholder returns and reinvestment planning.
Bears Say
Weak Cash ConversionVery low operating cash conversion versus reported earnings indicates earnings quality issues and suggests reliance on non-cash items or working-capital swings. This erodes the reliability of reported profits to fund dividends and investments, raising structural financing risk.
Thin And Softening MarginsLow and declining profitability margins constrain the company’s ability to absorb cost inflation, invest in growth, or improve returns. Persistent thin margins limit internal capital formation and make the business more sensitive to competitive pressure and input-cost shocks.
Mid-Range Returns On EquityROE in the mid-single digits suggests the business delivers moderate returns relative to capital employed. Over time, middling ROE can limit reinvestment payoff and shareholder value creation, particularly for a conglomerates peer set where higher returns are expected.
3353 FAQ
What was Medical Ikkou Group Co., Ltd.’s price range in the past 12 months?
Medical Ikkou Group Co., Ltd. lowest stock price was ¥2150.00 and its highest was ¥4410.00 in the past 12 months.
What is Medical Ikkou Group Co., Ltd.’s market cap?
Medical Ikkou Group Co., Ltd.’s market cap is ¥10.13B.
When is Medical Ikkou Group Co., Ltd.’s upcoming earnings report date?
Medical Ikkou Group Co., Ltd.’s upcoming earnings report date is Jul 13, 2026 which is in 95 days.
How were Medical Ikkou Group Co., Ltd.’s earnings last quarter?
Medical Ikkou Group Co., Ltd. released its earnings results on Apr 06, 2026. The company reported ¥87.16 earnings per share for the quarter, beating the consensus estimate of N/A by ¥87.16.
Is Medical Ikkou Group Co., Ltd. overvalued?
According to Wall Street analysts Medical Ikkou Group Co., Ltd.’s price is currently Overvalued.
Does Medical Ikkou Group Co., Ltd. pay dividends?
Medical Ikkou Group Co., Ltd. pays a Semiannually dividend of ¥60 which represents an annual dividend yield of 3.51%. See more information on Medical Ikkou Group Co., Ltd. dividends here
What is Medical Ikkou Group Co., Ltd.’s EPS estimate?
Medical Ikkou Group Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medical Ikkou Group Co., Ltd. have?
Medical Ikkou Group Co., Ltd. has 3,770,000 shares outstanding.
What happened to Medical Ikkou Group Co., Ltd.’s price movement after its last earnings report?
Medical Ikkou Group Co., Ltd. reported an EPS of ¥87.16 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.742%.
Which hedge fund is a major shareholder of Medical Ikkou Group Co., Ltd.?
Currently, no hedge funds are holding shares in JP:3353
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medical Ikkou Group Co., Ltd.
Medical Ikkou Group Co.,Ltd. operates dispensing pharmacies in Japan. The company is also involved in the operation of nursing homes, outpatient nursing care facilities, and home-visit nursing care facilities; wholesale of generic drugs; and rental of real estate properties, as well as invests in listed and unlisted stocks, M&A, etc. It operates 93 dispensing pharmacy stores. The company was founded in 1980 and is headquartered in Tsu, Japan.
Technical Analysis
LIKE, Inc.
―
Tamagawa Holdings Co., Ltd.
―
halmek holdings Co.,Ltd.
―
I. A Group Corporation
―
People, Dreams & Technologies Group Co., Ltd.
―